Cargando…
A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors
Cdc25 phosphatases have been considered promising targets for anticancer development due to the correlation of their overexpression with a wide variety of cancers. In the last two decades, the interest in this subject has considerably increased and many publications have been launched concerning thi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031484/ https://www.ncbi.nlm.nih.gov/pubmed/35458583 http://dx.doi.org/10.3390/molecules27082389 |
_version_ | 1784692400889790464 |
---|---|
author | Abdelwahab, Ahmed Bakr El-Sawy, Eslam Reda Hanna, Atef G. Bagrel, Denyse Kirsch, Gilbert |
author_facet | Abdelwahab, Ahmed Bakr El-Sawy, Eslam Reda Hanna, Atef G. Bagrel, Denyse Kirsch, Gilbert |
author_sort | Abdelwahab, Ahmed Bakr |
collection | PubMed |
description | Cdc25 phosphatases have been considered promising targets for anticancer development due to the correlation of their overexpression with a wide variety of cancers. In the last two decades, the interest in this subject has considerably increased and many publications have been launched concerning this issue. An overview is constructed based on data analysis of the results of the previous publications covering the years from 1992 to 2021. Thus, the main objective of the current review is to report the chemical structures of Cdc25s inhibitors and answer the question, how to design an inhibitor with better efficacy and lower toxicity? |
format | Online Article Text |
id | pubmed-9031484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90314842022-04-23 A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors Abdelwahab, Ahmed Bakr El-Sawy, Eslam Reda Hanna, Atef G. Bagrel, Denyse Kirsch, Gilbert Molecules Review Cdc25 phosphatases have been considered promising targets for anticancer development due to the correlation of their overexpression with a wide variety of cancers. In the last two decades, the interest in this subject has considerably increased and many publications have been launched concerning this issue. An overview is constructed based on data analysis of the results of the previous publications covering the years from 1992 to 2021. Thus, the main objective of the current review is to report the chemical structures of Cdc25s inhibitors and answer the question, how to design an inhibitor with better efficacy and lower toxicity? MDPI 2022-04-07 /pmc/articles/PMC9031484/ /pubmed/35458583 http://dx.doi.org/10.3390/molecules27082389 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Abdelwahab, Ahmed Bakr El-Sawy, Eslam Reda Hanna, Atef G. Bagrel, Denyse Kirsch, Gilbert A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title | A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title_full | A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title_fullStr | A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title_full_unstemmed | A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title_short | A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors |
title_sort | comprehensive overview of the developments of cdc25 phosphatase inhibitors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031484/ https://www.ncbi.nlm.nih.gov/pubmed/35458583 http://dx.doi.org/10.3390/molecules27082389 |
work_keys_str_mv | AT abdelwahabahmedbakr acomprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT elsawyeslamreda acomprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT hannaatefg acomprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT bagreldenyse acomprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT kirschgilbert acomprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT abdelwahabahmedbakr comprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT elsawyeslamreda comprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT hannaatefg comprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT bagreldenyse comprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors AT kirschgilbert comprehensiveoverviewofthedevelopmentsofcdc25phosphataseinhibitors |